PCM
EXAS

Prelude Capital Management’s Exact Sciences EXAS Stock Holding History

Prelude Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-131,830
Closed -$13.4M – 1325
2025
Q4 		$13.4M Buy
+131,830
New +$10.6M 0.99% 10
2025
Q3 		– Sell
-18,025
Closed -$958K – 1229
2025
Q2 		$958K Buy
+18,025
New +$916K 0.09% 270
2025
Q1 		– Sell
-21,700
Closed -$1.22M – 1292
2024
Q4 		$1.22M Buy
+21,700
New +$1.35M 0.08% 328
2024
Q2 		– Sell
-14,261
Closed -$985K – 1304
2024
Q1 		$985K Buy
+14,261
New +$902K 0.05% 406
2023
Q4 		– Sell
-4,131
Closed -$282K – 1185
2023
Q3 		$282K Buy
+4,131
New +$350K 0.02% 700
2023
Q1 		– Sell
-7,845
Closed -$388K – 1276
2022
Q4 		$388K Buy
+7,845
New +$321K 0.02% 678
2021
Q4 		– Sell
-2,210
Closed -$211K – 2042
2021
Q3 		$211K Buy
+2,210
New +$233K 0.01% 1335
2020
Q4 		– Sell
-490
Closed -$50K – 1487
2020
Q3 		$50K Buy
+490
New +$42.3K ﹤0.01% 1120
2020
Q2 		– Sell
-6,743
Closed -$391K – 2041
2020
Q1 		$391K Buy
6,743
+5,240
+349% +$425K 0.03% 348
2019
Q4 		$139K Buy
+1,503
New +$132K 0.01% 978
2018
Q3 		– Sell
-34,115
Closed -$2.04M – 1810
2018
Q2 		$2.04M Buy
34,115
+32,396
+1,885% +$1.74M 0.13% 149
2018
Q1 		$69K Buy
+1,719
New +$83.9K 0.01% 974
2016
Q4 		– Sell
-1,800
Closed -$33K – 1613
2016
Q3 		$33K Buy
+1,800
New +$31.7K ﹤0.01% 1186
2014
Q4 		– Sell
-4,085
Closed -$79K – 1968
2014
Q3 		$79K Buy
4,085
+3,727
+1,041% +$68.3K 0.01% 1200
2014
Q2 		$6K Buy
+358
New +$4.93K ﹤0.01% 1838

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Prelude Capital Management's EXAS Position: Q1 2026 in Review

Prelude Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 131,830 shares — an estimated $13.4M sold.

Prelude Capital Management first reported a position in EXAS in Q2 2014 and held it in 15 quarters. The position peaked at $13.4M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Prelude Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 131,830 Exact Sciences shares in Q1 2026, an estimated $13.4M.
  • Prelude Capital Management first reported a position in Exact Sciences in Q2 2014 and held it in 15 quarters.
  • Prelude Capital Management's Exact Sciences position peaked at $13.4M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.